Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease

Background and purpose: Cerebral microbleeds (CMBs) could contribute to an increased risk of intracerebral hemorrhage in patients with antithrombotic therapy (antiplatelets or anticoagulants). Antithrombotic agents are commonly prescribed to the patients with atrial fibrillation (AF) and/or rheumati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yajun, Liu, Junfeng, Zhang, Shuting, Li, Jie, Wei, Chenchen, Wang, Deren, Lin, Jing, Wang, Yanan, Wu, Bo, Zhang, Shihong, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336764/
https://www.ncbi.nlm.nih.gov/pubmed/30687227
http://dx.doi.org/10.3389/fneur.2018.01184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336764/
https://www.ncbi.nlm.nih.gov/pubmed/30687227
http://dx.doi.org/10.3389/fneur.2018.01184

Ejemplares similares